Thyroid cancer surveillance for recurrence is performed using ultrasound scan of neck, cross-sectional imaging in some patients, along with serum thyroglobulin (TG) to monitor disease burden in response to treatment (Robbins et al., 2004). The gene discussed is TG; the disease is thyroid cancer.